Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson &amp; Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

Rosenblum, Hannah G.; Hadler, Stephen C.; Moulia, Danielle; Shimabukuro, Tom T.; Su, John R.; Tepper, Naomi K.; Ess, Kevin C.; Woo, Emily Jane; Mba‐Jonas, Adamma; Alimchandani, Meghna; Nair, Narayan; Klein, Nicola P.; Hanson, Kayla E.; Markowitz, Lauri E.; Wharton, Melinda; McNally, Veronica; Romero, José R.; Talbot, H. Keipp; Lee, Grace M.; Daley, Matthew F.; Mbaeyi, Sarah; Oliver, Sara E.

doi:10.15585/mmwr.mm7032e4

Cited by 201 publications

(176 citation statements)

References 9 publications

Supporting

Mentioning

167

Contrasting

Unclassified

Order By: Relevance

“…The correct information about these potential harms and the use of COVID-19 vaccines is essential [34]. People should be educated about their individual benefits and risks associated with COVID-19 vaccination, and we must ensure that vaccine recipients are aware of risks and that they should seek care if they experience concerning symptoms [3,35].…”

Section: Discussionmentioning

confidence: 99%

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

et al. 2021

View full text Add to dashboard Cite

A 76 year-old female came to our observation one week after the vaccination with ChAdOx1 nCoV-19 AZD1222 for the onset of purpuric rash on her gluteal and legs regions associated with coxalgia and episodes of macrohaematuria. Henoch-Schönlein purpura (HSP) was diagnosed on the basis of the revised criteria developed by the European League Against Rheumatism, the Paediatric Rheumatology International Trials Organization, and the Paediatric Rheumatology European Society (EULAR/PRINTO/PRES). HSP is a common IgA-mediated small vessel vasculitis, typical of childhood, that affects several systems and is characterized by a tetrad of dermatological, abdominal, joint, and renal manifestations. The Etiology of HSP is not completely understood, but it was observed following upper respiratory tract infections, medications, vaccinations, and malignancies. HSP has previously been reported following immunization with various vaccines, mostly within 12 weeks post, suggesting a possible correlation. To our knowledge, this is the first report of the possible association between COVID-19 ChAdOx1 nCoV-19 AZD1222 and the onset of HSP in a previously healthy woman. No similar cases were reported amongst 23.848 participants in the ChAdOx1 nCoV-19 AZD1222 trial.

show abstract

Section: Discussionmentioning

confidence: 99%

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The GBS reporting rate was 7.8 cases per million Ad26.COV2.S vaccine doses administered, while it was highest among males aged 50–64 years, with 15.6 cases per million Ad26.COV2.S vaccine doses administered. The median age of patients, who developed GBS after Ad26.COV2.S, was 57 years (range: 24–76), 61% were males, and the median interval between vaccination and symptom onset was 13 days (range: 0–75 days) [ 39 ]. Most patients presented clinical recovery and one patient died [ 39 ].…”

mentioning

confidence: 99%

Serious complications of COVID-19 vaccines: A mini-review

Fragkou¹,

Dimopoulou²

2021

Metabolism Open

View full text Add to dashboard Cite

“… 29 Furthermore, herpes zoster or pityriasis rosea (PR) and PR-like eruptions, Guillain-Barré syndrome, and myocarditis following mRNA COVID-19 vaccination have been reported. 26 , 30 , 31 There will be clarity on the side effects with an increase in the available data.…”

Section: Discussionmentioning

confidence: 99%

Update on the COVID-19 Vaccine Research Trends: A Bibliometric Analysis

Xu¹,

Qu²,

Ren³

et al. 2021

IDR

View full text Add to dashboard Cite

Background:The coronavirus disease 2019 (COVID-19) pandemic is ravaging the world. To date, there are no standard therapies available to cure the disease. Consequently, research on COVID-19 vaccines is booming. This report aimed to assess the research trends of the global COVID-19 vaccines. Methods: The relevant publications on the COVID-19 vaccines were searched in the Web of Science Core Collection Database (WOSCC) database from December 2019 to 11 August 2021. The VOSviewer1.6.16 was used to assess the co-authorship, cooccurrence, citation of countries, institutions, authors, journals, and hotspot keywords. The HistCite TM (http://www.histcite.com/) software was used to calculate the total local citation score (TLCS) and total global citation score (TGCS) of each variable and generate the citation historiography graph of COVID-19 vaccine development using the citation time series analysis method. Results: A total of 5070 studies authored by 21,151 researchers and published by 1364 different journals were eventually included in this study. The bulk of the retrieved studies were original articles (n = 2401, 47.36%). Among these studies, 1204 (23.75%) were published in 2020. A total of 3863 (76.19%) were published in 2021 and 4295 (84.71%) were open access. The highest number of studies was conducted in the USA, followed by England, China, and Germany. The main partners of the USA were China, England, and

show abstract

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

Cited by 201 publications

References 9 publications

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

Serious complications of COVID-19 vaccines: A mini-review

Update on the COVID-19 Vaccine Research Trends: A Bibliometric Analysis

Contact Info

Product

Resources

About